]>
IRCT20211127053186N2 IRCT 2024-01-23 Tehran University of Medical Sciences The effect of chitosan wound dressing in the treatment of infected wounds Study of the effect of chitosan wound dressing containing antibiotics on recovering process of the infected wounds 2024-02-14 anticipated 20 Complete https://irct.ir/trial/74471 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is done in a simple way and the table of random numbers will be used as a tool. Even numbers are for the intervention group and odd numbers are for the control group. Then, according to the number of the studied sample, the corresponding numbers are extracted from the table of random numbers or using a computer, and each number is written on a card and placed in an envelope, and the envelopes are sealed, and on each envelope the number The patient is written. The first patient who is enrolled in the study and enters the study will be given the envelope related to patient number 1, patient number 2 will be given envelope number 2 and so on, and this will continue until the end of the study sample. In order to maintain randomization, the person who prepares the envelopes will be different from the person who registers the patients and provides the envelopes to the patients, Blinding description: Only study participants are blinded. This means that only the participants do not know which group they have been placed in and whether they have been prescribed a drug or a placebo. It is tried that the patients do not meet each other during their visits, and their appointments are made separately at different times. During wound dressing, all patients will be told that the same dressings will be used for them. 3 Infected wounds. Intervention 1: Intervention group: The wound dressing is prepared in the laboratory of Medical Biomaterials Research Center (MBRC) in Tehran University of Medical Sciences. Patients referred to Farmanieh Hospital are selected by a specialist doctor. A chitosan dressing containing antibiotics will be placed on the affected wound. The wound dressing is changed and controlled by the attending physician every day for a week. Intervention 2: Control group: Wound dressing is prepared in the laboratory of Medical Biomaterial Research Center (MBRC) in Tehran University of Medical Sciences. Patients referred to Farmanieh Hospital are selected by a specialist doctor. A chitosan dressing will be placed on the affected wound. The wound dressing is changed and controlled by the attending physician every day for a week. Yes - There is a plan to make this available What will be shared: The data from this study will be published as an article or a report. When: The access period starts 6 months after the results are published To whom: The resulting data will be available for researchers working in academic and scientific and clinical institutions Conditions: There are no special conditions. Where to obtain: To receive the data, applicants can refer to Tehran University of Medical Sciences, located on 16 Azar St. How to obtain: Researchers can access the data by searching the Internet. Comments:
public Somayeh Handali
Englebal, 16 Azar, Tehran University of Medical Sciences
Tehran Iran (Islamic Republic of) 1417653761 +98 21 8163 3619 handali_s81@yahoo.com Tehran University of Medical Sciences scientific Somayeh Handali
Englebal, 16 Azar, Tehran University of Medical Sciences
Tehran Iran (Islamic Republic of) 1417653761 +98 21 8163 3619 handali_s81@yahoo.com Tehran University of Medical Sciences Iran (Islamic Republic of) "Patients with surgical wounds" are eligible for the study. "Patients with ulcers caused by bedsores" are eligible for the study. "Patients with diabetic foot ulcers" are eligible for the study. "Patients with wounds caused by infectious " are eligible for the study. 40 years 80 years Both "Patients who have a deep wound with abscess, osteomyelitis, the presence of local or extensive non-debrideable gangrene" are not eligible for the study. "Patients with venous ulcers and evidence of malignancy in the wound area" are not eligible for the study. "Pregnant women diagnosed by a specialist doctor" are not eligible to enter the study. S01.0 Open wound of scalp Treatment - Drugs Treatment - Drugs Intervention group: The wound dressing is prepared in the laboratory of Medical Biomaterials Research Center (MBRC) in Tehran University of Medical Sciences. Patients referred to Farmanieh Hospital are selected by a specialist doctor. A chitosan dressing containing antibiotics will be placed on the affected wound. The wound dressing is changed and controlled by the attending physician every day for a week. Control group: Wound dressing is prepared in the laboratory of Medical Biomaterial Research Center (MBRC) in Tehran University of Medical Sciences. Patients referred to Farmanieh Hospital are selected by a specialist doctor. A chitosan dressing will be placed on the affected wound. The wound dressing is changed and controlled by the attending physician every day for a week. Wound healing percentage. Timepoint: The wound healing process is monitored every day for a week. Method of measurement: Taking a photo of the wound and comparing the photo of the first day with the photo of the seventh day. Tehran University of Medical Sciences Approved 2023-12-14 Ethics committee of Tehran University of Medical Sciences Englebal, 16 Azar St., Tehran University of Medical Sciences1417653761 Tehran Tehran Iran (Islamic Republic of)